Will FDA/CMS Parallel Review Idea Make Headway This Time?
Executive Summary
The possibility of simultaneous FDA and CMS evaluations of new health products is back in the front of agency officials' minds after a series of fits and starts over the past several years, says CMS Chief Medical Officer Barry Straube